Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Massanella, Marta ^a,d   Gómez Mora, Elisabet ^a   Carrillo, Jorge ^a   Curriu, Marta ^a   Ouchi, Dan ^a   Puig, Jordi ^b   Negredo, Eugènia ^b,c   Cabrera, Cecilia ^a   Clotet, Bonaventura ^a,b,c   Blanco, Julià ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cART; Cell death; HAART; Immunodiscordant; Immunosenescence; T cell subsets

Indexed keywords

ANTIRETROVIRUS AGENT; CD57 ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EX VIVO STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNODISCORDANT; IMMUNOLOGICAL PARAMETERS; IMMUNOSENESCENCE; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; HIV INFECTIONS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIGENS, CD57; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COMPARTMENTATION; CELL DEATH; CELL DIFFERENTIATION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 84937027268     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0601-2     Document Type: Article

References (45)

1. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141-155
2. Blanco J, Barretina J, Cabrera C, Gutiérrez A, Clotet B, Esté JA (2001) CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro. Virology 285:356-365
3. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML et al (2010) Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801
4. Breton G, Chomont N, Takata H, Fromentin R, Ahlers J, Filali-Mouhim A et al (2013) Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection. J Immunol 191:2194-2204
5. + T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis 48:328-337
6. Massanella M, Negredo E, Clotet B, Blanco J (2013) Immunodiscordant responses to HAART-mechanisms and consequences. Expert Rev Clin Immunol 9:1135-1149
7. Corbeau P, Reynes J (2011) Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood 117:5582-5590
8. Negredo E, Massanella M, Puig J, Pérez-Alvarez N, Gallego-Escuredo JM, Villarroya J et al (2010) Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clin Infect Dis 50:1300-1308
9. Marchetti G, Gori A, Casabianca A, Magnani M, Franzetti F, Clerici M et al (2006) Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 20:1727-1736
10. + T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol 136:501-506
11. + T cell homeostasis in progressive simian immunodeficiency virus infection. J Exp Med 209:641-651
12. + T cells. Blood 101:2711-2720
13. + T-cell activation and senescence but not with lower effector memory T-cell function. Clin Immunol 120:163-170
14. Méndez-Lagares G, Díaz L, Correa-Rocha R, León Leal JA, Ferrando-Martínez S, Ruiz-Mateos E et al (2013) Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects. Clin Microbiol Infect 19:558-565
15. Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H et al (2011) Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 204:1217-1226
16. + effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204:2171-2185
17. Massanella M, Negredo E, Pérez-Alvarez N, Puig J, Ruiz-Hernández R, Bofill M et al (2010) CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS 24:959-968
18. Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J et al (2013) Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med 11:68
19. Massanella M, Curriu M, Carrillo J, Gómez E, Puig J, Navarro J et al (2013) Assessing main death pathways in T lymphocytes from HIV infected individuals. Cytometry A 83:648-658
20. R Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org
21. Chirullo B, Sgarbanti R, Limongi D, Shytaj IL, Alvarez D, Das B et al (2013) A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes. Cell Death Dis 4:e944
22. Deeks SG (2009) Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 17:118-123
23. Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P et al (2005) Swiss HIV Cohort Study: Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis 41:361-372
24. Gutiérrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P et al (2008) Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy. Curr HIV Res 6:100-107
25. Piketty C, Weiss L, Thomas F, Mohamed AS, Belec L, Kazatchkine MD (2001) Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J Infect Dis 183:1328-1335
26. Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F et al (2012) CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med 9:e1001194
27. Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA et al (2008) Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 47:553-558
28. Moore DM, Hogg RS, Chan K, Tyndall M, Yip B, Montaner JSG (2006) Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response. AIDS 20:371-377
29. Appay V, Fastenackels S, Katlama C, Ait-Mohand H, Schneider L, Guihot A et al (2011) Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 25:1813-1822
30. Méndez-Lagares G, García-Pergañeda A, del Mardel Pozo-Balado M, Genebat M, Ruiz-Mateos E, García García M et al (2012) Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother 67:1228-1237
31. + recovery upon long-term virologically suppressive HAART. AIDS 24:1455-1460
32. Solomon A, Cameron PU, Bailey M, Dunne AL, Crowe SM, Hoy JF et al (2003) Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity. J Infect Dis 187:1915-1923
33. Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E et al (2000) Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis 181:141-147
34. + central memory T cells. J Exp Med 204:79-91
35. Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J et al (2008) HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA 105:19851-19856
36. Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K et al (2009) IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 113:6304-6314
37. Massanella M, Ouchi D, Marfil S, Llibre JM, Puertas MC, Buzón MJ et al (2014) Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals. PLoS One 9:e114142
38. +T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175:8415-8423
39. + T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34:633-644
40. Gupta S (2005) Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 205:114-129
41. +CD4 germinal center Th cells. J Immunol 177:4927-4932
42. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S et al (2014) Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 10:e1003853
43. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ et al (2011) T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 217:207-213
44. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ et al (2011) T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 203:452-463
45. + T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality. PLoS Pathog 10:e1004078